Situationmaterial
US FDA approves Replimune's skin cancer drug
Carried more widely than almost anything else in the last 30 days
◆ Sectors
Biotech
◆ Where
United States
◆ Timeline
- 6 August 2026US FDA approves Replimune's skin cancer drugkfgo.com
- 7 August 2026FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant ...biospace.com
- 8 August 2026FDA Grants Accelerated Approval to Tudriqev Plus Nivolumab for Advanced Melanomaoncodaily.com
- 9 August 2026FDA Approves Replimune's Tudriqev for Advanced Melanoma After Two Previous Rejectionsmedicaldaily.com
- 10 August 2026New Melanoma Drug Based On Herpes Virus Granted FDA Accelerated Approvalusnews.com
- 10 August 2026FDA reverses course, approves melanoma therapy after 2 rejectionsbeckersoncology.com
◆ Connected developments
Situations Wire finds semantically close to this one. Proximity, not cause.
◆ Share
◆ Wire has not analysed this situation yet
Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.
◆ Evidence
15 reports · 14 domains